201 related articles for article (PubMed ID: 27890378)
1. Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
Guariento S; Karawajczyk A; Bull JA; Marchini G; Bielska M; Iwanowa X; Bruno O; Fossa P; Giordanetto F
Bioorg Med Chem Lett; 2017 Jan; 27(1):24-29. PubMed ID: 27890378
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.
Li YS; Tian H; Zhao DS; Hu DK; Liu XY; Jin HW; Song GP; Cui ZN
Bioorg Med Chem Lett; 2016 Aug; 26(15):3632-5. PubMed ID: 27289320
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment.
Zhang R; Li H; Zhang X; Li J; Su H; Lu Q; Dong G; Dou H; Fan C; Gu Z; Mu Q; Tang W; Xu Y; Liu H
Eur J Med Chem; 2021 Feb; 211():113004. PubMed ID: 33218684
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Liao Y; Guo Y; Li S; Wang L; Tang Y; Li T; Chen W; Zhong G; Song G
Bioorg Med Chem Lett; 2018 Apr; 28(7):1188-1193. PubMed ID: 29545101
[TBL] [Abstract][Full Text] [Related]
6. Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors.
Gorja DR; Mukherjee S; Meda CL; Deora GS; Kumar KL; Jain A; Chaudhari GH; Chennubhotla KS; Banote RK; Kulkarni P; Parsa KV; Mukkanti K; Pal M
Org Biomol Chem; 2013 Apr; 11(13):2075-9. PubMed ID: 23436140
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents.
Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S
Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors.
Huang L; Shan W; Zhou Q; Xie J; Lai K; Li X
Bioorg Med Chem Lett; 2014 Jan; 24(1):249-53. PubMed ID: 24300734
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification.
Liao Y; Jia X; Tang Y; Li S; Zang Y; Wang L; Cui ZN; Song G
Bioorg Med Chem Lett; 2019 Nov; 29(22):126720. PubMed ID: 31610942
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
Purushothaman B; Arumugam P; Kulsi G; Song JM
Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and molecular modeling of heterocyclic bioisostere as potent PDE4 inhibitors.
Almatary AM; Elmorsy MA; El Husseiny WM; Selim KB; El-Sayed MA
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700403. PubMed ID: 29573453
[TBL] [Abstract][Full Text] [Related]
12. Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure-Activity Relationships.
Gràcia J; Buil MA; Castro J; Eichhorn P; Ferrer M; Gavaldà A; Hernández B; Segarra V; Lehner MD; Moreno I; Pagès L; Roberts RS; Serrat J; Sevilla S; Taltavull J; Andrés M; Cabedo J; Vilella D; Calama E; Carcasona C; Miralpeix M
J Med Chem; 2016 Dec; 59(23):10479-10497. PubMed ID: 27933955
[TBL] [Abstract][Full Text] [Related]
13. Discovery of oxazole-based PDE4 inhibitors with picomolar potency.
Kuang R; Shue HJ; Xiao L; Blythin DJ; Shih NY; Chen X; Gu D; Schwerdt J; Lin L; Ting PC; Cao J; Aslanian R; Piwinski JJ; Prelusky D; Wu P; Zhang J; Zhang X; Celly CS; Billah M; Wang P
Bioorg Med Chem Lett; 2012 Apr; 22(7):2594-7. PubMed ID: 22401864
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
Taltavull J; Serrat J; Gràcia J; Gavaldà A; Córdoba M; Calama E; Montero JL; Andrés M; Miralpeix M; Vilella D; Hernández B; Beleta J; Ryder H; Pagès L
Eur J Med Chem; 2011 Oct; 46(10):4946-56. PubMed ID: 21871695
[TBL] [Abstract][Full Text] [Related]
15. Novel Roflumilast analogs as soft PDE4 inhibitors.
Boland S; Alen J; Bourin A; Castermans K; Boumans N; Panitti L; Vanormelingen J; Leysen D; Defert O
Bioorg Med Chem Lett; 2014 Sep; 24(18):4594-4597. PubMed ID: 25149511
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Docking and Anti-Inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors.
Grewal AS; Lather V; Pandita D; Dalal R
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):58-67. PubMed ID: 28618988
[TBL] [Abstract][Full Text] [Related]
17. Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect.
Tang L; Huang C; Zhong J; He J; Guo J; Liu M; Xu JP; Wang HT; Zhou ZZ
Eur J Med Chem; 2019 Apr; 168():221-231. PubMed ID: 30822711
[TBL] [Abstract][Full Text] [Related]
18. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.
Chu Z; Xu Q; Zhu Q; Ma X; Mo J; Lin G; Zhao Y; Gu Y; Bian L; Shao L; Guo J; Ye W; Li J; He G; Xu Y
Eur J Med Chem; 2021 Mar; 213():113171. PubMed ID: 33482600
[TBL] [Abstract][Full Text] [Related]
20. Triazole-Pyridine Dicarbonitrile Targets Phosphodiesterase 4 to Induce Cytotoxicity in Lung Carcinoma Cells.
Keerthy HK; Mohan S; Basappa ; Bharathkumar H; Rangappa S; Svensson F; Bender A; Mohan CD; Rangappa KS; Bhatnagar R
Chem Biodivers; 2019 Sep; 16(9):e1900234. PubMed ID: 31287204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
